Groundbreaking Cell Therapy NRTX-1001 Promises Over 90% Seizure Reduction: A New Hope for Drug-Resistant Epilepsy Patients
Neurona Therapeutics, a clinical-stage biotherapeutics company, has presented new data from its ongoing Phase I/II clinical trial of a one-time dose of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy (MTLE). The data shows a promising reduction in seizure frequency in the first and second patients at one year and seven-months post-treatment, respectively. The […]
Orgenesis and UC Davis: The Dynamic Duo Transforming Cell and Gene Therapy
Orgenesis Inc., a global biotech company, and the University of California, Davis (UC Davis) have announced a partnership to deploy Orgenesis Mobile Processing Units and Labs (OMPULs) at medical and academic institutions within the University of California system. The agreement outlines a phased approach where Orgenesis will install and operate OMPULs, enabling their proprietary point-of-care […]
Stem Cells in Space: The Unexpected Solution to Age-Related Diseases?
Age-related diseases like stroke, cancer, dementia, and other neurodegenerative conditions present significant challenges to patients and families, and pose an escalating health burden in the United States. Stem cell-based therapies may provide a solution, but creating large numbers of stem cells is challenging. To address this, scientists in regenerative medicine are using the International Space […]
Stem Cell Game-Changer: BioCardia Receives Patent for Innovative Therapeutic Approach
Sunnyvale, California-based BioCardia, Inc. [Nasdaq: BCDA], a company specializing in the development of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced on May 9, 2023, that the United States Patent Office has awarded them Patent Number 11,642,377. The patent, titled “Bone Marrow Derived Neurokinin-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells […]
Transforming Lives with Cutting-Edge Science: Orchard Therapeutics Takes Center Stage at ASGCT Conference
Orchard Therapeutics, a global gene therapy leader, announced that six presentations from its hematopoietic stem cell (HSC) gene therapy platform will be featured at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) in Los Angeles from May 16-20, 2023. The presentations will include updated results from the company’s ongoing […]
A New Era in Pain Management: CELL Technologies Pursues Groundbreaking Stem Cell Therapy Approval
CELL Technologies Inc. has submitted clinical data from its stem cell program for pain management to Health Canada for approval. This follows a regulatory meeting on March 31st, 2023, and if approved, CELL would become the first regulatory-approved stem cell provider in North America. The data submitted covers three studies in arthritis, degenerative disc disease, […]
Defying Gravity: How Space-Based Stem Cell Research Could Revolutionize Medicine
Cedars-Sinai investigators, in partnership with Axiom Space of Houston, are preparing to send stem cells to space in early May to study the effects of microgravity on their production. This groundbreaking mission, funded by NASA, will involve astronauts manufacturing induced pluripotent stem cells (iPSCs) aboard the International Space Station (ISS) for the first time. The […]
Hair Today, Gray Tomorrow? Researchers Discover Pathway to Prevent Hair Graying
A new study from NYU Grossman School of Medicine sheds light on the process of hair graying and could potentially offer a pathway to reverse or prevent it. The research focused on melanocyte stem cells (McSCs), which control hair color by maturing into pigment-producing cells. The study found that these cells have a unique ability […]
Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients
A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]